• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏康复中结构化的糖尿病护理常规与心肌梗死后糖尿病检出率的增加和治疗改善相关:一项全国性观察研究。

Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study.

机构信息

Department of Clinical Sciences Malmö, Lund University, Jan Waldenströms gata 15 plan 3, 205 02, Malmö, Sweden.

Department of Cardiology, Skane University Hospital, Malmö, Sweden.

出版信息

Cardiovasc Diabetol. 2024 Sep 3;23(1):330. doi: 10.1186/s12933-024-02425-6.

DOI:10.1186/s12933-024-02425-6
PMID:39227843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11373097/
Abstract

BACKGROUND

Despite the detrimental impact of abnormal glucose metabolism on cardiovascular prognosis after myocardial infarction (MI), diabetes is both underdiagnosed and undertreated. We investigated associations between structured diabetes care routines in cardiac rehabilitation (CR) and detection and treatment of diabetes at one-year post-MI.

METHODS

Center-level data was derived from the Perfect-CR survey, which evaluated work routines applied at Swedish CR centers (n = 76). Work routines involving diabetes care included: (1) routine assessment of fasting glucose and/or HbA1c, (2) routine use of oral glucose tolerance test (OGTT), (3) having regular case rounds with diabetologists, and (4) whether glucose-lowering medication was adjusted by CR physicians. Patient-level data was obtained from the national MI registry SWEDEHEART (n = 7601, 76% male, mean age 62.6 years) and included all post-MI patients irrespective of diabetes diagnosis. Using mixed-effects regression we estimated differences between patients exposed versus. not exposed to the four above-mentioned diabetes care routines. Outcomes were newly detected diabetes and the proportion of patients receiving oral glucose-lowering medication at one-year post-MI.

RESULTS

Routine assessment of fasting glucose/HbA1c was performed at 63.2% (n = 48) of the centers, while 38.2% (n = 29) reported using OGTT for detecting glucose abnormalities. Glucose-lowering medication adjusted by CR physicians (n = 13, 17.1%) or regular case rounds with diabetologists (n = 7, 9.2%) were less frequently reported. In total, 4.0% of all patients (n = 304) were diagnosed with diabetes during follow-up and 17.9% (n = 1361) were on oral glucose-lowering treatment one-year post-MI. Routine use of OGTT was associated with a higher rate of newly detected diabetes at one-year (risk ratio [95% confidence interval]: 1.62 [1.26, 1.98], p = 0.0007). At one-year a higher proportion of patients were receiving oral glucose-lowering medication at centers using OGTT (1.22 [1.07, 1.37], p = 0.0046) and where such medication was adjusted by CR physicians (1.31 [1.06, 1.56], p = 0.0155). Compared to having none of the structured diabetes care routines, the more routines implemented the higher the rate of newly detected diabetes (from 0 routines: 2.7% to 4 routines: 6.3%; p for trend = 0.0014).

CONCLUSIONS

Having structured routines for diabetes care implemented within CR can improve detection and treatment of diabetes post-MI. A cluster-randomized trial is warranted to ascertain causality.

摘要

背景

尽管异常葡萄糖代谢对心肌梗死后心血管预后有不利影响,但糖尿病的诊断和治疗不足。我们研究了心脏康复(CR)中结构化糖尿病护理常规与心肌梗死后一年时糖尿病的检测和治疗之间的关系。

方法

中心水平的数据来自 Perfect-CR 调查,该调查评估了瑞典 CR 中心应用的工作常规(n=76)。涉及糖尿病护理的工作常规包括:(1)常规评估空腹血糖和/或糖化血红蛋白(HbA1c),(2)常规使用口服葡萄糖耐量试验(OGTT),(3)定期与糖尿病专家进行病例讨论,以及(4)CR 医生是否调整降血糖药物。患者水平的数据来自全国心肌梗死登记处 SWEDEHEART(n=7601,76%为男性,平均年龄 62.6 岁),包括所有心肌梗死后患者,无论是否诊断为糖尿病。使用混合效应回归,我们估计了暴露于上述四种糖尿病护理常规与未暴露于常规的患者之间的差异。结果是心肌梗死后一年新诊断的糖尿病和接受口服降血糖药物治疗的患者比例。

结果

有 63.2%(n=48)的中心常规评估空腹血糖/HbA1c,而有 38.2%(n=29)的中心报告使用 OGTT 检测血糖异常。CR 医生调整降血糖药物(n=13,17.1%)或定期与糖尿病专家进行病例讨论(n=7,9.2%)的情况较少。在随访期间,共有 4.0%(n=304)的所有患者被诊断为糖尿病,17.9%(n=1361)的患者在心肌梗死后一年接受口服降血糖药物治疗。常规使用 OGTT 与一年时新诊断糖尿病的发生率较高相关(风险比[95%置信区间]:1.62[1.26,1.98],p=0.0007)。一年时,使用 OGTT 的中心接受口服降血糖药物治疗的患者比例更高(1.22[1.07,1.37],p=0.0046),且 CR 医生调整该药物的比例更高(1.31[1.06,1.56],p=0.0155)。与没有任何结构化糖尿病护理常规相比,实施的常规越多,新诊断糖尿病的发生率越高(从无常规:2.7%到有 4 种常规:6.3%;趋势 p=0.0014)。

结论

在 CR 中实施结构化的糖尿病护理常规可以改善心肌梗死后的糖尿病检测和治疗。需要进行一项集群随机试验以确定因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5e/11373097/b3349b60b2a8/12933_2024_2425_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5e/11373097/b3349b60b2a8/12933_2024_2425_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5e/11373097/b3349b60b2a8/12933_2024_2425_Fig1_HTML.jpg

相似文献

1
Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study.心脏康复中结构化的糖尿病护理常规与心肌梗死后糖尿病检出率的增加和治疗改善相关:一项全国性观察研究。
Cardiovasc Diabetol. 2024 Sep 3;23(1):330. doi: 10.1186/s12933-024-02425-6.
2
Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.急性心肌梗死患者伴新发血糖异常的长期预后:口服葡萄糖耐量试验和 HbA1c 的预测价值。
Cardiovasc Diabetol. 2021 Jun 14;20(1):122. doi: 10.1186/s12933-021-01315-5.
3
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.当代冠状动脉药物洗脱支架治疗"无症状"糖尿病、糖尿病前期或血糖正常的所有患者 3 年临床结局:来自 BIO-RESORT 无症状糖尿病研究。
Catheter Cardiovasc Interv. 2020 Aug;96(2):E110-E118. doi: 10.1002/ccd.28536. Epub 2019 Oct 17.
4
Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006.首次心肌梗死后起始降血糖药物治疗的时间趋势 - 1997 年至 2006 年的全国性研究。
Cardiovasc Diabetol. 2011 Jan 19;10:5. doi: 10.1186/1475-2840-10-5.
5
Rethinking the accuracy of 75g glucose used in the oral glucose tolerance test in the diagnosis and management of diabetes.重新审视口服葡萄糖耐量试验中使用的75g葡萄糖在糖尿病诊断和管理中的准确性。
Prim Care Diabetes. 2017 Dec;11(6):555-560. doi: 10.1016/j.pcd.2017.06.003.
6
J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.在接受经皮冠状动脉介入治疗的急性心肌梗死合并糖尿病患者中,长期血糖控制与死亡率之间的 J 型曲线关系。
Cardiovasc Diabetol. 2021 Dec 15;20(1):234. doi: 10.1186/s12933-021-01428-x.
7
Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke.比较口服葡萄糖耐量试验和糖化血红蛋白在急性脑卒中患者糖代谢紊乱检测中的应用。
Cardiovasc Diabetol. 2020 Dec 5;19(1):204. doi: 10.1186/s12933-020-01182-6.
8
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry.糖尿病、二甲双胍和心肌梗死后的血糖降低治疗:来自 SWEDEHEART 注册研究的见解。
Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120973676. doi: 10.1177/1479164120973676.
9
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.在初级保健中整合断食模拟饮食方案可减少 2 型糖尿病患者对药物的需求并改善血糖控制:一项为期 12 个月的随机对照试验。
Diabetologia. 2024 Jul;67(7):1245-1259. doi: 10.1007/s00125-024-06137-0. Epub 2024 Mar 28.
10
Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.稳定型冠状动脉疾病患者的糖尿病状态和血糖控制与缺血和出血结局的关系:CORONOR 注册研究 5 年随访结果。
J Am Heart Assoc. 2018 May 4;7(10):e008354. doi: 10.1161/JAHA.117.008354.

本文引用的文献

1
The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南的“十诫”
Eur Heart J. 2024 Apr 14;45(15):1298-1300. doi: 10.1093/eurheartj/ehad881.
2
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
3
Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR study.
心梗后心脏康复中达到关键风险因素目标的组织和患者水平预测因素:完美-CR 研究。
Int J Cardiol. 2023 Jan 15;371:40-48. doi: 10.1016/j.ijcard.2022.09.012. Epub 2022 Sep 9.
4
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs.二肽基肽酶-4 抑制剂、胰高血糖素样肽-1 受体激动剂和钠-葡萄糖共转运蛋白 2 抑制剂对心肾结局的影响:23 项心血管结局试验的网络荟萃分析。
Cardiovasc Diabetol. 2022 Mar 16;21(1):42. doi: 10.1186/s12933-022-01474-z.
5
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
6
Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.急性心肌梗死患者伴新发血糖异常的长期预后:口服葡萄糖耐量试验和 HbA1c 的预测价值。
Cardiovasc Diabetol. 2021 Jun 14;20(1):122. doi: 10.1186/s12933-021-01315-5.
7
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry).瑞典心脏二级预防与心脏康复注册研究(SWEDEHEART CR注册研究)。
Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):431-437. doi: 10.1093/ehjqcco/qcab039.
8
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry.糖尿病、二甲双胍和心肌梗死后的血糖降低治疗:来自 SWEDEHEART 注册研究的见解。
Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120973676. doi: 10.1177/1479164120973676.
9
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.筛查伴冠状动脉疾病的糖代谢紊乱患者的血糖紊乱和危险因素管理:需要大幅改善的持续挑战:ESC EORP EUROASPIRE V 报告
Diabetes Care. 2020 Apr;43(4):726-733. doi: 10.2337/dc19-2165. Epub 2020 Feb 20.
10
Risk and management of pre-diabetes.糖尿病前期的风险与管理。
Eur J Prev Cardiol. 2019 Dec;26(2_suppl):47-54. doi: 10.1177/2047487319880041.